UNICA IRIS Institutional Research Information System

CARDIA, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 169.728
NA - Nord America 6.912
AS - Asia 3.267
SA - Sud America 455
Continente sconosciuto - Info sul continente non disponibili 241
AF - Africa 94
OC - Oceania 9
Totale 180.706
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 167.308
US - Stati Uniti d'America 6.764
SG - Singapore 1.198
CN - Cina 1.196
UA - Ucraina 547
SE - Svezia 494
DE - Germania 432
BR - Brasile 368
VN - Vietnam 272
FI - Finlandia 233
GB - Regno Unito 221
FR - Francia 189
IN - India 102
KR - Corea 87
HK - Hong Kong 85
NL - Olanda 84
CA - Canada 80
BD - Bangladesh 64
AT - Austria 33
RU - Federazione Russa 32
IQ - Iraq 31
PL - Polonia 29
MA - Marocco 28
PK - Pakistan 28
ID - Indonesia 27
TR - Turchia 27
JP - Giappone 26
ES - Italia 25
IR - Iran 25
MX - Messico 24
AR - Argentina 23
BE - Belgio 20
PT - Portogallo 18
CO - Colombia 17
VG - Isole Vergini Britanniche 17
ZA - Sudafrica 16
PH - Filippine 14
EC - Ecuador 13
IE - Irlanda 13
EG - Egitto 12
TN - Tunisia 12
SA - Arabia Saudita 10
UZ - Uzbekistan 10
VE - Venezuela 10
AU - Australia 8
JM - Giamaica 8
KE - Kenya 8
KG - Kirghizistan 8
IL - Israele 7
NP - Nepal 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
DZ - Algeria 6
KZ - Kazakistan 6
LT - Lituania 6
MY - Malesia 6
PE - Perù 6
RO - Romania 6
TW - Taiwan 6
BO - Bolivia 5
CH - Svizzera 5
CR - Costa Rica 5
HU - Ungheria 5
PY - Paraguay 5
DK - Danimarca 4
GT - Guatemala 4
MU - Mauritius 4
AL - Albania 3
ET - Etiopia 3
IS - Islanda 3
JO - Giordania 3
MD - Moldavia 3
PA - Panama 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
GR - Grecia 2
KH - Cambogia 2
LK - Sri Lanka 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SI - Slovenia 2
UY - Uruguay 2
A1 - Anonimo 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
LU - Lussemburgo 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 180.461
Salva come PNG Salva come JPEG
Città #
Cagliari 162.895
Uta 3.107
Singapore 676
Ashburn 590
Chandler 494
San Jose 481
Fairfield 429
Woodbridge 371
Dallas 349
Boardman 336
Nyköping 315
Jacksonville 300
Ann Arbor 282
Houston 236
Beijing 227
Dearborn 208
Wilmington 200
Seattle 173
Los Angeles 153
Helsinki 149
New York 145
Cambridge 134
Santa Clara 128
Council Bluffs 119
Hefei 100
Shanghai 100
Lauterbourg 95
Nanjing 93
Milan 88
Seoul 84
The Dalles 82
Ho Chi Minh City 73
Hong Kong 72
Boston 65
Hanoi 60
Rome 59
Buffalo 47
Guangzhou 44
Nanchang 38
Toronto 38
Munich 37
Shenyang 35
Redwood City 33
São Paulo 31
Orem 30
Vienna 29
Changsha 27
Chicago 26
Parma 25
Naples 23
San Diego 23
Tokyo 23
Casablanca 22
Dong Ket 22
Tianjin 22
Columbus 21
Verona 21
Hebei 20
Chennai 19
Florence 19
Jinan 19
Amsterdam 18
Brussels 18
Jiaxing 18
La Puente 18
Nürnberg 18
Redondo Beach 18
Brooklyn 17
Frankfurt am Main 17
Road Town 17
Turin 17
Denver 16
London 16
Sassari 16
Montreal 15
Atlanta 14
Haiphong 14
Orange 14
Mountain View 13
Norwalk 13
Warsaw 13
Auburn Hills 12
Catania 12
Padova 12
Washington 12
Baghdad 11
Hangzhou 11
Johannesburg 11
Nuremberg 11
Stockholm 11
Turku 11
Bologna 10
Dublin 10
Kingston 10
Phoenix 10
Rende 10
Rio de Janeiro 10
Augusta 9
Bari 9
Istanbul 9
Totale 174.683
Salva come PNG Salva come JPEG
Nome #
Formulation and characterization studies of trimethyl chitosan / sodium alginate nanoparticles for targeted drug delivery 4.621
Inhalable polymer-glycerosomes as safe and effective carriers for rifampicin delivery to the lungs 4.618
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 4.331
Nanoincorporation of curcumin in polymer-glycerosomes and evaluation of their in vitro-in vivo suitability as pulmonary delivery systems 3.940
Investigating the interactions of resveratrol with phospholipid vesicle bilayer and the skin: NMR studies and confocal imaging 3.906
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.788
Preparazione di nanoparticelle di TMC per il rilascio di farmaci a livello oculare 3.538
Preparation and characterization of TMC nanoparticles for colon specific drug delivery 3.504
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.498
Sintesi e caratterizzazione chimico-fisica di un derivato del chitosano per la realizzazione di sistemi nanoparticellari 3.480
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.364
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 3.299
Synthesis And Characterization Of A Chitosan Derivative For The Preparation Of Nanoparticles 3.287
PREPARATION OF TMC NANOPARTICLES FOR OCULAR DELIVERY 3.273
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 3.231
Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol 3.029
Trimethyl chitosan hydrogel nanoparticles for progesterone delivery in neurodegenerative disorders 2.985
NANOPARTICELLE A BASE DI TMC E SA PER LA VEICOLAZIONE NOSE TO BRAIN 2.830
SINTESI DI TMC A DIVERSO GRADO DI QUATERNIZZAZIONE PER LA REALIZZAZIONE DI SISTEMI NANOPARTICELLARI 2.816
null 2.749
PREPARAZIONE E CARATTERIZZAZIONE DI SISTEMI NANOPARTICELLARI DI TMC PER LA VEICOLAZIONE DI UN AGENTE ANTINFIAMMATORIO FITOTERAPICO MIRATO AL COLON 2.628
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.625
Synthesis and characterization of new phthalhydrazothiazole derivatives: A preliminary investigation on their activity against hepatocellular carcinoma 2.549
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.470
1H NMR study of the interaction of trans-resveratrol with soybean phosphatidylcholine liposomes 2.426
Preparazione e caratterizzazione di formulazioni cosmetiche contenenti olio di Neem 2.392
Nanoparticelle per la veicolazione nasale del Progesterone per il trattamento della malattia di Alzheimer 2.357
SYNTHESIS AND CHARACTERIZATION OF A CHITOSAN DERIVATIVE FOR THE PREPARATION OF NANOPARTICLES 2.322
New promising scaffolds for the inhibition of monoamine oxidase B 2.318
Preparation and Characterization of TMC/SA nanoparticles for nose to brain drug delivery 2.303
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.280
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.188
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.164
Approcci formulativi per ottimizzare l’incapsulazione nanoparticellare della Curcumina 2.154
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 2.117
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.097
Needle-Free Jet Injectors and Nanosuspensions: Exploring the Potential of an Unexpected Pair 2.060
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.985
Nanosuspension-Based Dissolvable Microneedle Arrays to Enhance Diclofenac Skin Delivery 1.953
null 1.949
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.942
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.937
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.893
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors 1.874
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.822
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.716
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.693
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.676
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.670
Attività fungicida di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Candida spp. 1.654
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease 1.641
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.601
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.480
Transcutol® p containing slns for improving 8-methoxypsoralen skin delivery 1.466
Shape based computer aided similarity screening: a valid tool in the discovery of new scaffolds for the inhibition of HIV-1 reverse transcriptase associated ribonuclease H function 1.439
null 1.415
null 1.406
Synthesis of new arylidencycloalkylpyrazoles of potential biological interest 1.202
Preparazione di nanoparticelle TMC/Alginato per la veicolazione al SNC 1.177
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.138
Synthesis, molecular modelling, inhibitory acivity, and selectivity towards monoamine oxidase of new heterocyclic scaffold 1.122
Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and DFT calculations. Investigation on a case of very remote Hammett correlation 1.116
Proniosomal formulation encapsulating pomegranate peel extract for nutraceutical applications 1.066
Progettazione e sintesi di 4-(5-ariliden-3-metil-4-ossotiazolidin-2-ilidenamino)benzensulfonamidi e 4-(5-alchiliden-3-metil-4-ossotiazolidin-2-ilidenammino)benzensulfonamidi quali potenziali inibitori selettivi delle ciclossigenasi 2 1.053
Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones 1.047
Computational approaches for discovery and optimization of monoamine oxidase B inhibitors 1.043
Pulmonary delivery of curcumin and beclomethasone dipropionate in a multicomponent nanosuspension for the treatment of bronchial asthma 1.003
Synthesis and antimicrobial activity of novel arylideneisothiosemicarbazones 984
1-benzenesulfonamide-1(H)-pyrazoles and 3-benzenesulfonamide-4-tiazolidinones, two promising scaffolds for the design of cycloxygenase inhibitors 978
Tri-substituted thiazolines as promising scaffolds for the design of efficient COX inhibitors 949
CoMFA studies of non-covalent monoamine oxidase inhibitors 948
null 943
Combining induced fit docking and molecular dynamics simulations to predict the binding mode of new monoamine oxidase B inhibitors 932
1-acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazole; a new scaffold for monoaminoxidase inhibitors: design, synthesis, and biological properties 921
Attività di un derivato isotiosemicarbazonico ciclico nei confronti di biofilm di Candida albicans FLC-S e FLC-R in combinazione con AMB 918
Sintesi di cicloalchilidenidrazo-4-ariltiazoli ad elevata attività inibitrice selettiva sulla isoforma B delle monoammino ossidasi 913
Computational and experimental study of non-covalent monoamine oxidase inhibitors 888
Novel MAO-B selective inhibitors developed using computational methods 874
Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives 863
Topoisomerase I: synthesis of a new class of potential inhibitors 838
Aumento della sensibilità all’AmB di biofilm di Candida albicans fluconazolo-resistente nell’impiego combinato con derivati ciclici isotiosemicarbazonici 830
Impact of solid lipid nanoparticles on 3T3 fibroblasts viability and lipid profile: The effect of curcumin and resveratrol loading 821
null 818
Studio dell’attività di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Aspergillus spp 772
null 735
Strategie alternative per la profilassi delle infezioni sostenute da Candida albicans contratte in ambiente ospedaliero mediante isotiosemicarbazoni ciclici 710
Isothiosemicarbazones as alternative approach to the therapy of infections sustained by Candida albicans 697
null 693
Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodent 688
Studio della attività di una nuova classe di isotiosemicarbazoni nei confronti di Aspergillus spp. di isolamento clinico. 661
null 617
Synthesis of new arylidencycloalkylpyrazoles of biological interest 613
null 610
Bentonite- and Palygorskite-Based Gels for Topical Drug Delivery Applications 561
Isonicotinoylhydrazothiazoles and isonicotinoyl-N-4-substituted thiosemicarbazides: Synthesis, characterization, and anti-mycobacterial activity 516
Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and density functional theory calculations. Investigation on a case of very remote Hammett correlation 492
Clay-Based Hydrogels as Drug Delivery Vehicles of Curcumin Nanocrystals for Topical Application 474
Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives 421
New cycloalkylpyrazoles as potential cyclooxygenase inhibitors 406
Production of liposomes by microfluidics: The impact of post-manufacturing dilution on drug encapsulation and lipid loss 363
Totale 179.163
Salva come PNG Salva come JPEG
Categoria #
all - tutte 219.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.270
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.156 0 765 320 378 597 490 481 334 590 590 805 806
2022/202312.131 945 1.574 1.399 1.156 816 1.103 753 965 670 997 1.198 555
2023/202413.892 494 654 1.153 916 1.496 2.115 2.025 1.026 819 715 1.134 1.345
2024/202522.055 3.608 4.952 5.648 2.362 1.250 1.438 1.603 154 255 209 239 337
2025/20267.732 476 292 774 630 487 536 1.112 716 636 1.148 495 430
2026/2027533 244 289 0 0 0 0 0 0 0 0 0 0
Totale 180.706